Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Friedreich's ataxia causes thin, weak hair with surface damage and cavities.

Methylene blue staining effectively reveals detailed nerve structures in rat snouts.

A Chinese man with KID syndrome had a new mutation in the GJB2 gene.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

A new compound effectively inhibits human 5α-reductase 1.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Researchers developed a method to grow hair follicle cells for transplantation using a special chip.

TCDD changes skin cell growth and keratin production in mice.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

EVAL membranes help create cell structures that can regrow hair follicles.

The ammonia-free hair dye is safe and improves hair shine, color, moisture, porosity, and combability.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.